About My Health Careers Internship MedBlogs Contact us
Medindia
LOGIN REGISTER
Advertisement

Gene Therapy to Treat Eye Diseases Shows Potential

by Kathy Jones on August 15, 2010 at 12:52 PM
Font : A-A+

 Gene Therapy to Treat Eye Diseases Shows Potential

Using gene therapy to treat eye diseases may be a reality in future thanks to the efforts from scientists.

Two reports describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration.

Advertisement

Basil Pawlyk and colleagues from Harvard Medical School and Massachusetts Eye and Ear Infirmary (Boston, MA) delivered the human gene for RGPR-interacting protein-1 to mice affected with Leber congenital amaurosis (LCA), a condition linked to a mutated form of RPGRIP1 that causes degeneration of photoreceptors in the eye.

The researchers packaged the gene in an adeno-associated virus (AAV) vector and injected the vector under the retinas of the affected mice.

They demonstrated expression of the human gene in the photoreceptors, with correct localization to the cilia.
Advertisement

Further evaluation revealed improved function and survival of the photoreceptors in the treated eyes.

The authors concluded that the results of this study validate a gene therapy design that could serve as the basis for a future clinical trial in patients affected by this form of LCA.

In the same issue, Kamolika Roy, Linda Stein, and Shalesh Kaushal from University of Massachusetts Medical School (Worcester) review the use of recombinant AAV vectors for gene therapy to treat ocular diseases.

Based on the success of three early-stage clinical trials in LCA, they conclude that this approach appears "to be a safe, effective, and long-term treatment for LCA, a previously untreatable disorder."

In the second study, the researchers concluded that rAAV-mediated gene therapy is "the most suitable gene therapy treatment approach for ocular diseases."

"The successful correction of this photoreceptor defect in a relevant mouse model of LCA should usher in a new wave of translational research in retinal degeneration syndromes," said Dr. James M. Wilson, Editor-in-Chief of Human Gene Therapy.

The study has been published in the current issue of Human Gene Therapy.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Emotional Healing
Psychosis Risk Related to Cat Parasite
Sedentary Behavior Precipitates Night-Time Hot Flashes
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Reiki and Pranic Healing Genetic Testing of Diseases Eye Pancreas Vision LASIK Surgery Facts Allergy Eye Drops Routine Eye Examination Quiz On Eye Donation 

Recommended Reading
Conjunctivitis
Conjunctivitis or Pink Eye causes redness and soreness of the conjunctiva and is responsible for 1% ...
LASIK Eye Surgery
Lasik / Laser eye surgery is a treatment, which improves the vision in patients suffering from eye ....
Amblyopia
Amblyopia is the loss of one eye''s ability to see details. Amblyopia is otherwise known as lazy ......
Allergy Eye Drops
Eye allergies are treated with different types of eye drops such as lubricants, antihistamines, NSAI...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laborat...
Routine Eye Examination
A comprehensive eye exam can take an hour or more, depending on the doctor and the number and comple...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use